Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Net Shares Issued and Repurchased (2013 - 2025)

Palatin Technologies' (PTN) quarterly Net Shares Issued and Repurchased came in at $48000.0 in Q4 2025, up 805.83% quarter-over-quarter from $5299.0 in Q2 2024.

Analysis

Palatin Technologies (PTN) Net Shares Issued and Repurchased (2013 - 2025) Analysis & Trends

Palatin Technologies (PTN) has reported Net Shares Issued and Repurchased for 13 consecutive years, with $48000.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Shares Issued and Repurchased changed N/A year-over-year to $48000.0; the trailing twelve-month figure through Dec 2025 stood at $48000.0 (changed N/A YoY), and the FY2024 full-year result was $5299.0, down 99.26% from the prior year.
  • Net Shares Issued and Repurchased climbed to $48000.0 in Q4 2025 per PTN's latest filing, from $5299.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $141844.0 in Q2 2021 and bottomed at $1211.0 in Q2 2022.
  • Historically, Net Shares Issued and Repurchased has averaged $48048.4 across 5 years, with a median of $17056.0 in 2022.
  • The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased sank 99.15% in 2022, then surged 294.47% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $118152.0 in 2021, then sank by 85.56% to $17056.0 in 2022, then slumped by 71.99% to $4777.0 in 2023, then advanced by 10.93% to $5299.0 in 2024, then surged by 805.83% to $48000.0 in 2025.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $48000.0, $5299.0, and $4777.0 for Q4 2025, Q2 2024, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Palatin Technologies 46.98 Mn 46.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 48,000.00
Jun 30, 2024 5,299.00
Jun 30, 2023 4,777.00
Sep 30, 2022 17,056.00
Jun 30, 2022 1,211.00
Sep 30, 2021 118,152.00
Jun 30, 2021 141,844.00
Sep 30, 2020 154,500.00
Jun 30, 2020 5.78 Mn
Sep 30, 2019 77,100.00
Jun 30, 2019 2.34 Mn
Sep 30, 2018 133,851.00
Jun 30, 2018 4.18 Mn
Jun 30, 2017 4.12 Mn
Jun 30, 2016 355,000.00
Jun 30, 2015 975,800.00
Jun 30, 2014 603,400.00
Jun 30, 2013 1.81 Mn